| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 9 | 2011 | 469 | 1.090 |
Why?
|
| Thioredoxins | 3 | 2010 | 27 | 0.920 |
Why?
|
| Nitric Oxide Synthase Type III | 8 | 2008 | 187 | 0.810 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 518 | 0.740 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2013 | 699 | 0.700 |
Why?
|
| Up-Regulation | 9 | 2011 | 832 | 0.680 |
Why?
|
| Aortic Aneurysm | 2 | 2021 | 224 | 0.660 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2010 | 125 | 0.660 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 371 | 0.650 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2006 | 254 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 482 | 0.570 |
Why?
|
| Palmitic Acid | 4 | 2010 | 28 | 0.530 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 665 | 0.510 |
Why?
|
| Cells, Cultured | 15 | 2012 | 2969 | 0.470 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2013 | 230 | 0.450 |
Why?
|
| Activating Transcription Factor 2 | 3 | 2010 | 16 | 0.440 |
Why?
|
| Endothelial Cells | 6 | 2010 | 535 | 0.440 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2013 | 85 | 0.400 |
Why?
|
| Pulmonary Medicine | 1 | 2013 | 32 | 0.390 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 119 | 0.360 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 2355 | 0.350 |
Why?
|
| Insulin | 2 | 2006 | 1145 | 0.340 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 236 | 0.320 |
Why?
|
| Thrombomodulin | 1 | 2010 | 18 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 3 | 2006 | 305 | 0.320 |
Why?
|
| Lung Diseases | 1 | 2013 | 400 | 0.300 |
Why?
|
| Metformin | 1 | 2010 | 167 | 0.280 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 173 | 0.270 |
Why?
|
| Cytomegalovirus | 2 | 2006 | 259 | 0.270 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2021 | 185 | 0.270 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 179 | 0.260 |
Why?
|
| Fatty Acids | 1 | 2009 | 362 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 240 | 0.250 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2012 | 103 | 0.250 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2006 | 114 | 0.240 |
Why?
|
| Aorta, Thoracic | 6 | 2013 | 536 | 0.240 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 470 | 0.240 |
Why?
|
| Resistin | 1 | 2006 | 30 | 0.240 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1944 | 0.230 |
Why?
|
| Repressor Proteins | 1 | 2010 | 777 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 1217 | 0.220 |
Why?
|
| Apoptosis | 4 | 2021 | 1861 | 0.220 |
Why?
|
| Glucose | 1 | 2009 | 848 | 0.220 |
Why?
|
| Carrier Proteins | 1 | 2009 | 1024 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 225 | 0.200 |
Why?
|
| Procollagen-Proline Dioxygenase | 3 | 2008 | 31 | 0.200 |
Why?
|
| Angiotensin II | 2 | 2013 | 134 | 0.190 |
Why?
|
| Blotting, Western | 4 | 2010 | 1018 | 0.180 |
Why?
|
| China | 2 | 2013 | 287 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2013 | 4674 | 0.170 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2010 | 233 | 0.170 |
Why?
|
| Aorta | 6 | 2013 | 529 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2013 | 2567 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 139 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 420 | 0.140 |
Why?
|
| Humans | 28 | 2021 | 131501 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2012 | 3452 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2012 | 1569 | 0.130 |
Why?
|
| Protein Binding | 2 | 2012 | 1710 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1236 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2006 | 588 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 642 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2012 | 3861 | 0.110 |
Why?
|
| RNA | 2 | 2008 | 531 | 0.110 |
Why?
|
| Introns | 4 | 2008 | 287 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 2014 | 11 | 0.110 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 39 | 0.110 |
Why?
|
| Aortitis | 1 | 2012 | 7 | 0.100 |
Why?
|
| Elastic Tissue | 1 | 2012 | 19 | 0.100 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2012 | 11 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2013 | 86 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 39 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 97 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 112 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 79 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 75 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2012 | 84 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2143 | 0.090 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 188 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2013 | 864 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 64 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 39 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 361 | 0.090 |
Why?
|
| Collagen Type III | 2 | 2013 | 23 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 33 | 0.090 |
Why?
|
| Vasculitis | 1 | 2011 | 47 | 0.090 |
Why?
|
| DNA Primers | 2 | 2009 | 609 | 0.080 |
Why?
|
| Atherosclerosis | 2 | 2011 | 947 | 0.080 |
Why?
|
| Collagen Type I | 2 | 2013 | 114 | 0.080 |
Why?
|
| Public Health | 1 | 2013 | 276 | 0.080 |
Why?
|
| Plasmids | 2 | 2009 | 455 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 356 | 0.080 |
Why?
|
| Reference Values | 1 | 2012 | 691 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 955 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 53 | 0.080 |
Why?
|
| Fenofibrate | 1 | 2010 | 59 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 89 | 0.080 |
Why?
|
| Aged | 7 | 2014 | 21238 | 0.080 |
Why?
|
| Transfection | 3 | 2006 | 960 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 18 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 191 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 293 | 0.080 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 31 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 2009 | 31 | 0.080 |
Why?
|
| Middle Aged | 8 | 2014 | 28839 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1610 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2010 | 322 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2006 | 230 | 0.070 |
Why?
|
| Octamer Transcription Factors | 1 | 2008 | 9 | 0.070 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2008 | 18 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 874 | 0.070 |
Why?
|
| Nucleotides | 1 | 2008 | 90 | 0.070 |
Why?
|
| Histones | 2 | 2008 | 518 | 0.070 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2007 | 12 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 8 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 336 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 2205 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2006 | 21 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1487 | 0.060 |
Why?
|
| Binding Sites | 2 | 2006 | 1202 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 57 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 33 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 58 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 117 | 0.060 |
Why?
|
| Mice | 3 | 2012 | 18470 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 482 | 0.060 |
Why?
|
| Elastin | 1 | 2005 | 32 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 1357 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1624 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1313 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2005 | 82 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 804 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 158 | 0.050 |
Why?
|
| Animals | 5 | 2013 | 34335 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1397 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 549 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 317 | 0.050 |
Why?
|
| Male | 9 | 2014 | 65158 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4762 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 492 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 617 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 6273 | 0.040 |
Why?
|
| Cell Line | 1 | 2006 | 2603 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2006 | 678 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1390 | 0.040 |
Why?
|
| Gene Expression | 3 | 2012 | 1500 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2010 | 34 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 138 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2006 | 2436 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1490 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2012 | 659 | 0.030 |
Why?
|
| Female | 7 | 2014 | 71086 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2862 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12937 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2008 | 694 | 0.030 |
Why?
|
| Rats | 2 | 2013 | 3454 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 463 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 1956 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 567 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 45 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 47 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 93 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 54 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 109 | 0.020 |
Why?
|
| ADAMTS1 Protein | 1 | 2012 | 16 | 0.020 |
Why?
|
| ADAMTS4 Protein | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2081 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2013 | 62 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 2782 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 99 | 0.020 |
Why?
|
| Heparin | 1 | 2014 | 205 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 307 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 116 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 152 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 55 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3614 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2013 | 113 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 230 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 328 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 71 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 853 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1153 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2010 | 51 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 146 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 594 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 179 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 634 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 666 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 289 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 181 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 135 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 436 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 400 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2985 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 18 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2006 | 20 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 56 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2008 | 313 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 126 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 88 | 0.020 |
Why?
|
| Luciferases | 1 | 2006 | 127 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2462 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 106 | 0.010 |
Why?
|
| Response Elements | 1 | 2006 | 99 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 173 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 157 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 297 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 588 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2005 | 350 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3403 | 0.010 |
Why?
|
| Adult | 3 | 2014 | 31666 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 340 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4515 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 751 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 794 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 1085 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 926 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1442 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2655 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1831 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 3411 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6916 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 20918 | 0.000 |
Why?
|